| Date | Time | Source | Headline | Symbol | Company |
| 03/05/2013 | 12:38PM | Zacks | Allergan Reaches 52-Week High - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/04/2013 | 11:30AM | Zacks | Allergan - MAP Acquisition Update - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 5:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 5:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 5:23PM | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 5:21PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 4:01PM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 3:54PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 3:54PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 9:00AM | Business Wire | Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. & Intent to Exerc... | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/14/2013 | 2:11PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/14/2013 | 1:48PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/12/2013 | 1:14PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/11/2013 | 5:19PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/11/2013 | 2:59PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/11/2013 | 1:56PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/11/2013 | 1:56PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/08/2013 | 3:52PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/08/2013 | 2:15PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/08/2013 | 1:37PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/07/2013 | 4:59PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/07/2013 | 9:00AM | Business Wire | Allergan, Inc. & MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Per... | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/05/2013 | 2:22PM | Dow Jones News | UPDATE: Strong Botox Sales Help Lift Allergan's Profits 16% | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/05/2013 | 11:28AM | Zacks | AGN Earnings Miss but Guidance Tops - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/05/2013 | 10:00AM | Dow Jones News | Allergan 4th-Quarter Profit Rose 16% Amid Growing Revenue, Fewer Charges | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/04/2013 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/01/2013 | 1:08PM | GlobeNewswire Inc. | The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of MAP Pharmaceut | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 02/01/2013 | 11:50AM | Zacks | Update on AGN's Acquisition of MAP - Analyst Blog | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/31/2013 | 4:20PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |
| 01/31/2013 | 4:01PM | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NASDAQ:MAPP | Map Pharmaceuticals, Inc. (MM) |